Publicacións (34) Publicacións de Pablo Vidal Cortes

2023

  1. A blood microRNA classifier for the prediction of ICU mortality in COVID-19 patients: a multicenter validation study

    Respiratory Research, Vol. 24, Núm. 1

  2. A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients

    Medicina Intensiva, Vol. 47, Núm. 1, pp. 23-33

  3. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

  4. Effects of intubation timing in patients with COVID-19 throughout the four waves of the pandemic: a matched analysis

    The European respiratory journal, Vol. 61, Núm. 3

  5. Key Factors Associated With Pulmonary Sequelae in the Follow-Up of Critically Ill COVID-19 Patients

    Archivos de Bronconeumologia, Vol. 59, Núm. 4, pp. 205-215

  6. Management of Patients with Suspected or Confirmed Antibiotic Allergy: Executive Summary of Guidelines from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC)

    Journal of investigational allergology & clinical immunology, Vol. 33, Núm. 2, pp. 95-101

  7. Management of patients with suspected or confirmed antibiotic allergy. Executive summary of guidance from the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Allergy and Clinical Immunology (SEAIC), the Spanish Society of Hospital Pharmacy (SEFH) and the Spanish Society of Intensive Medicine and Coronary Care Units (SEMICYUC)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 3, pp. 181-186

  8. Procalcitonin and C-reactive protein to rule out early bacterial coinfection in COVID-19 critically ill patients

    Intensive Care Medicine, Vol. 49, Núm. 8, pp. 934-945

  9. Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study

    The Journal of infection, Vol. 86, Núm. 3, pp. 256-308

  10. Ten Issues to Update in Nosocomial or Hospital-Acquired Pneumonia: An Expert Review

    Journal of Clinical Medicine, Vol. 12, Núm. 20

2022

  1. Current Positioning against Severe Infections Due to Klebsiella pneumoniae in Hospitalized Adults

    Antibiotics, Vol. 11, Núm. 9

  2. Enhancing sepsis management through machine learning techniques: A review

    Medicina Intensiva, Vol. 46, Núm. 3, pp. 140-156

  3. Impact of one year of pandemic on Spanish Intensive Care Units

    Revista Espanola de Quimioterapia, Vol. 35, Núm. 4, pp. 392-400

  4. Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis

    Intensive Care Medicine, Vol. 48, Núm. 11, pp. 1593-1606

  5. Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units

    Medicina Intensiva, Vol. 46, Núm. 2, pp. 81-89

  6. Resuscitation strategy for patients with sepsis and septic shock

    Medicina Intensiva, Vol. 46, pp. 60-71

  7. Treatment of severe multi-drug resistant Pseudomonas aeruginosa infections

    Medicina Intensiva, Vol. 46, Núm. 9, pp. 508-520

2021

  1. Correction to: The evolution of the ventilatory ratio is a prognostic factor in mechanically ventilated COVID-19 ARDS patients (Critical Care, (2021), 25, 1, (331), 10.1186/s13054-021-03727-x)

    Critical Care

  2. Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study

    Annals of Intensive Care, Vol. 11, Núm. 1

  3. Covid-19 and acute respiratory distress syndrome. Impact of corticosteroid treatment and predictors of poor outcome

    Revista Espanola de Quimioterapia, Vol. 34, Núm. 1, pp. 33-43